Catalent
CTLT
#1507
Rank
NZ$20.36 B
Marketcap
$112.17
Share price
0.00%
Change (1 day)
37.93%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Market cap: NZ$20.36 Billion

As of January 2025 Catalent has a market cap of NZ$20.36 Billion. This makes Catalent the world's 1507th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$20.36 B-0.35%
2024NZ$20.43 B59.19%
2023NZ$12.83 B0.59%
2022NZ$12.75 B-61.97%
2021NZ$33.55 B41.24%
2020NZ$23.75 B94.1%
2019NZ$12.23 B80.8%
2018NZ$6.76 B-11.92%
2017NZ$7.68 B58.28%
2016NZ$4.85 B6.62%
2015NZ$4.55 B3.37%
2014NZ$4.40 B

End of Day market cap according to different sources

On Jan 20th, 2025 the market cap of Catalent was reported to be:

NZ$20.36 Billion
by Yahoo Finance info icon info icon
NZ$20.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$3.68 B-81.91%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.33 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.94 B-36.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$1.40 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA